{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:14:51Z","timestamp":1761488091011},"reference-count":33,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T00:00:00Z","timestamp":1217376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The standard hormonal therapy with currently available antiandrogens and the leutinizing hormone releasing hormone (LHRH) analogs is not effective in the hormone\u2010refractory stage of prostate cancer due to changes in androgen receptor (AR) signaling axis. In this refractory stage, AR continues to play a significant role in the growth of cancer cells even though the cancer cells are no longer dependent on the level of circulating androgens.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>A series of 11\u03b2\u2010\u0394<jats:sup>9<\/jats:sup>\u201019 nortestosterone compounds were designed through structure\u2010based rationale and tested for their binding affinity against AR and glucocorticoid receptor (GR) using fluorescence polarization assays, their agonistic ability to induce AR dependent transcription using PSA\u2010driven report gene assays, and their growth inhibitory affects against a series of AR positive (LAPC4, LNCap, and CWR22R) and negative human prostate cancer cell lines (PC3) using MTT cell proliferation assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>This study proposes the design of novel bifunctional antiandrogens based on the conjugation of 11\u03b2 and\/or 7\u03b1\u2010\u0394<jats:sup>9<\/jats:sup>\u201019 nortestosterone class of steroidal compounds to the synthetic ligand for FK506\u2010binding proteins. As a critical step towards the development of bifunctional antiandrogens, highly potent and AR\u2010specific lead compounds were identified using in vitro data. The lead compounds identified in this study possessed low binding affinity for GR, indicating the absence of undesirable antiglucocorticoid activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The results of this study validate our drug discovery rationale based on the structural biology of AR and pave the pay for future development of bifunctional compounds in order to block AR function in hormone refractory stage of prostate cancer. Prostate 68: 1570\u20131581, 2008. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pros.20821","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T13:47:18Z","timestamp":1217425638000},"page":"1570-1581","source":"Crossref","is-referenced-by-count":6,"title":["Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer"],"prefix":"10.1002","volume":"68","author":[{"given":"Pratap","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurulingappa","family":"Hallur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi K.","family":"Anchoori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oladapo","family":"Bakare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-8-1-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm972"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700416"},{"issue":"5","key":"e_1_2_1_5_2","first-page":"986","article-title":"17\u2010Allylamino\u201017\u2010demethoxygeldanamycin induces the degradation of androgen receptor and HER\u20102\/neu and inhibits the growth of prostate cancer xenografts","volume":"8","author":"Solit DB","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-5-8"},{"issue":"4","key":"e_1_2_1_7_2","first-page":"1008","article-title":"Disruption of androgen receptor function inhibits proliferation of androgen\u2010refractory prostate cancer cells","volume":"62","author":"Zegarra\u2010Moro OL","year":"2002","journal-title":"Cancer Res"},{"issue":"13","key":"e_1_2_1_8_2","first-page":"5038","article-title":"Conversion from a paracrine to an autocrine mechanism of androgen\u2010stimulated growth during malignant transformation of prostatic epithelial cells","volume":"61","author":"Gao J","year":"2001","journal-title":"Cancer Res"},{"issue":"15","key":"e_1_2_1_9_2","first-page":"3299","article-title":"Development of an androgen receptor\u2010null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC\u201082 human prostate cancer cells","volume":"58","author":"Gao J","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-022038"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2442"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20044"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1551"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.09.036"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M407046200"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020274"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2005.01.005"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/346671a0"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.1953"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7694365"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.10.6845"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1101262"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja035176q"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.03.012"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20187"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20542"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500381102"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611711200"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(01)00568-8"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0342515"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.102"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507464200"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10199"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.20821","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.20821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:52:11Z","timestamp":1699980731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.20821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,30]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1002\/pros.20821"],"URL":"https:\/\/doi.org\/10.1002\/pros.20821","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,30]]}}}